Clinical trials
10 active studies led by Verastem, Inc., of 27 in all
Source: ClinicalTrials.gov, Studies with Verastem, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 10Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Verastem, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Verastem, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- verastem.com
- Home country
- United States
- Stock listing
- NASDAQ: VSTM
- Type
- Medicines
See them on ClinicalTrials.gov (opens in a new tab)
US drug approvals
1 approvals with a product on the US market
- Avmapki Fakzynja Co-Pack (Copackaged) NDA219616 · approved 8 May 2025
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1526119.
Trials over time
Studies Verastem, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Verastem, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Verastem, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Verastem, Inc. is in.
From our blog
Stories on the topics Verastem, Inc. works in.
Women's Health Supplements: A Growing Focus
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read